Eugene OR 子宫内膜癌临床试验
8项针对 子宫内膜癌的研究正在 Eugene及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
招募中3 期
- Oncology Associates of Oregon, P.C. ( Site 8005), Eugene
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
招募中3 期
- Willamette Valley Cancer Institute and Research Center - Eugene, Eugene
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
招募中3 期
- Research Site, Eugene
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
招募中1/2 期
- USOR Oncology Associates of Oregon, P.C., Eugene
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
招募中3 期
- Research Site, Eugene
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
招募中2 期
- 517, Eugene
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
招募中2 期
- Oncology Associates of Oregon, P.C., Eugene
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
招募中2/3 期
- Oncology Associates of Oregon, Eugene
其他城市的 子宫内膜癌试验
- Houston, TX69 项研究
- New York City, NY53 项研究
- Boston, MA50 项研究
- Arlington, VA39 项研究
- Nashville, TN37 项研究
- Los Angeles, CA35 项研究
- St. Louis, MO29 项研究
- Philadelphia, PA29 项研究
- San Antonio, TX27 项研究
- Columbus, OH26 项研究
- Chicago, IL26 项研究
- Queens, NY26 项研究
Eugene的其他研究
- 非小细胞肺癌13 项研究
- 卵巢癌9 项研究
- 慢性淋巴细胞白血病7 项研究
- 乳腺癌7 项研究
- 转移性癌症6 项研究
- 癌症（所有类型）6 项研究
- 多发性骨髓瘤6 项研究
- 肺癌5 项研究
- 黄斑变性5 项研究
- 药物使用与成瘾5 项研究
- 肥胖症4 项研究
- 湿性黄斑变性3 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月1日。每项研究自行设定入选标准，由研究团队决定谁能参与。